Agenda

7:00-8:00 am Registration / Breakfast / Networking / Exhibits

(breakfast served from 7:30-8:00 am)

8:00-8:15 am Welcome and program highlights

8:15-9:00 am Product Theater: Gilead - Marcela Mazo, MD

9:00-9:30 am Break/Networking and Exhibit Hall Viewing

9:30-10:30 am Nan Chen, MD: Updates in TNBC - Combinations, Immunotherapy and PARP Inhibitors

9:30-10:00 am Keynote | 10:00-10:30 am Panel discussion

10:30-10:45 am Break - networking and exhibit hall viewing

11:00-11:55 am Julie Nangia, MD: Managing High-Risk Patients and Chemoprevention/Supportive Care, Including HRT

10:45-11:15 am Keynote | 11:15-11:45 am Panel discussion

11:45 am -12:45 pm Lunch Buffet

12:00-12:30 pm Jason Mouabbi, MD: Updated in ER+ Breast Cancer

12:45-1:45 pm De-escalation Strategies in Breast Cancer Management

1:00-1:55 pm David Page, MD: HER2+ Breast Cancer - ADCs & Novel Combinations

2:00-2:30 pm Keynote | 2:30-2:55 pm Panel discussion

3:00 pm Closing

Session topics and scheduling subject to change.